通过体外方法对阿育吠陀制剂哥克苏罗迪丸的抗尿路结石活性研究。
Antiurolithiatic activity of gokhsuradi churan, an ayurvedic formulation by in vitro method.
作者信息
Kumar Bagepalli Srinivasa Ashok, Kuruba Lakshman, Khan Saleemulla, Saran Gopi Setty
机构信息
Department of Pharmacognosy, Sri K.V.College of Pharmacy, Chickballapur, Karnataka, India.
出版信息
Adv Pharm Bull. 2013;3(2):477-9. doi: 10.5681/apb.2013.080. Epub 2013 Aug 20.
Abstract
PURPOSE
Gokhsuradi churna is an ayurvedic formulation, was investigate for antiurolithiatic activity.
METHODS
Calcium oxalate crystallization was induced by the addition of 0.01M sodium oxalate solutions in synthetic urine and nucleation method.
RESULTS
The effect of Gokhsuradi Churna exhibited a concentration dependent inhibition of on calcium oxalate crystallization and nucleation.
CONCLUSION
The present studies suggest that Gokhsuradi churna has a potential inhibition of calcium oxalate crystallization exhibited and nucleation. Gokhsuradi Churna showed potent antiurolethiatic activity.
摘要
目的
戈克苏拉迪 churn（一种阿育吠陀配方制剂）被研究其抗尿路结石活性。
方法
通过在合成尿液中添加 0.01M 草酸钠溶液并采用成核法诱导草酸钙结晶。
结果
戈克苏拉迪 churn 的作用表现出对草酸钙结晶和成核的浓度依赖性抑制。
结论
目前的研究表明，戈克苏拉迪 churn 对草酸钙结晶和成核具有潜在抑制作用。戈克苏拉迪 churn 显示出强大的抗尿路结石活性。
相似文献
1
Antiurolithiatic activity of gokhsuradi churan, an ayurvedic formulation by in vitro method.通过体外方法对阿育吠陀制剂哥克苏罗迪丸的抗尿路结石活性研究。
Adv Pharm Bull. 2013;3(2):477-9. doi: 10.5681/apb.2013.080. Epub 2013 Aug 20.
2
Calcium oxalate crystallization kinetics at different concentrations of human and artificial urine, with a constant calcium to oxalate ratio.在钙与草酸盐比例恒定的情况下，不同浓度的人体尿液和人工尿液中草酸钙的结晶动力学。
Urol Res. 1999 Aug;27(4):231-7. doi: 10.1007/s002400050115.
3
Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.特发性复发性草酸钙尿石症男性患者餐后尿中草酸钙成核与磷酸钙成核及结石形成强度有关吗？有助于深入了解尿游离柠檬酸盐和蛋白质可能作用的研究。
Clin Chem Lab Med. 2004 Mar;42(3):283-93. doi: 10.1515/CCLM.2004.052.
4
Increased Sulfation in Sulfated Galactans Enhances Antioxidant and Antiurolithiatic Activities and Protects HK-2 Cell Death Induced by Sodium Oxalate.硫酸化半乳聚糖中硫酸化程度的增加可增强其抗氧化和抗结石活性，并可保护 HK-2 细胞免受草酸钠诱导的细胞死亡。
Mar Drugs. 2022 Jun 7;20(6):382. doi: 10.3390/md20060382.
5
Antiurolithiatic activity of Boldoa purpurascens aqueous extract: An in vitro and in vivo study.Boldoa purpurascens 水提物的溶石活性：一项体内外研究。
J Ethnopharmacol. 2020 May 10;253:112691. doi: 10.1016/j.jep.2020.112691. Epub 2020 Feb 21.
6
Inhibition by citrate of spontaneous precipitation of calcium oxalate in vitro.枸橼酸盐在体外对草酸钙自发沉淀的抑制作用。
J Bone Miner Res. 1987 Jun;2(3):215-20. doi: 10.1002/jbmr.5650020308.
7
Evaluation of antiurolithiatic and antioxidant potential of Lepidagathis prostrata: A Pashanbhed plant.平卧鳞花草（一种破石草属植物）的抗尿路结石及抗氧化潜力评估
Pharm Biol. 2016 Jul;54(7):1237-45. doi: 10.3109/13880209.2015.1066397. Epub 2015 Jul 14.
8
In vitro inhibition of calcium oxalate crystallization and crystal adherence to renal tubular epithelial cells by Terminalia arjuna.阿朱那诃子对草酸钙结晶的体外抑制作用及晶体对肾小管上皮细胞的黏附作用
Urolithiasis. 2016 Apr;44(2):117-25. doi: 10.1007/s00240-015-0822-0. Epub 2015 Sep 30.
9
Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.白蛋白介导的草酸钙晶体成核作用：对预防结石形成的影响。
Kidney Int. 1999 May;55(5):1776-86. doi: 10.1046/j.1523-1755.1999.00426.x.
10
Effects of an extract from Herniaria hirsuta on calcium oxalate crystallization in vitro.硬毛卷耳提取物对草酸钙体外结晶的影响。
BJU Int. 2000 Apr;85(6):621-5. doi: 10.1046/j.1464-410x.2000.00485.x.
引用本文的文献
1
Pharmacological Evaluation of Safoof-e-Pathar Phori- A Polyherbal Unani Formulation for Urolithiasis.Safoof-e-Pathar Phori（一种用于治疗尿石症的多草药尤纳尼配方）的药理学评价
Front Pharmacol. 2021 Apr 14;12:597990. doi: 10.3389/fphar.2021.597990. eCollection 2021.
2
Assessment of calcium oxalate crystal inhibition potential, antioxidant activity and amino acid profiling in horse gram (): high altitude farmer's varieties.马豆（：高海拔地区农民品种）中草酸钙晶体抑制潜力、抗氧化活性及氨基酸谱分析
3 Biotech. 2020 Sep;10(9):402. doi: 10.1007/s13205-020-02394-z. Epub 2020 Aug 22.
本文引用的文献
1
Inhibition of crystallization of calcium oxalate by the extraction of Tamarix gallica L.盐生柽柳提取物对草酸钙结晶的抑制作用
Urol Res. 2008 Dec;36(6):283-7. doi: 10.1007/s00240-008-0157-1. Epub 2008 Nov 11.
2
Molecular modulation of calcium oxalate crystallization by osteopontin and citrate.骨桥蛋白和柠檬酸盐对草酸钙结晶的分子调节作用
Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1811-5. doi: 10.1073/pnas.0307900100. Epub 2004 Feb 6.
3
Annexin II is present on renal epithelial cells and binds calcium oxalate monohydrate crystals.膜联蛋白II存在于肾上皮细胞上，并与一水草酸钙晶体结合。
J Am Soc Nephrol. 2003 Feb;14(2):289-97. doi: 10.1097/01.asn.0000046030.24938.0a.
4
Crystal-cell interaction and apoptosis in oxalate-associated injury of renal epithelial cells.草酸相关肾上皮细胞损伤中的晶体-细胞相互作用与细胞凋亡
J Am Soc Nephrol. 1999 Nov;10 Suppl 14:S457-63.
5
A new approach to studying inhibitors of calcium oxalate crystal growth.一种研究草酸钙晶体生长抑制剂的新方法。
Urol Res. 1993 Mar;21(2):101-8. doi: 10.1007/BF01788827.
6
Association of calcium oxalate monohydrate crystals with MDCK cells.
Kidney Int. 1995 Jul;48(1):129-38. doi: 10.1038/ki.1995.276.
7
Changes in calcium oxalate crystal, morphology as a function of concentration.草酸钙晶体形态随浓度的变化。
Invest Urol. 1980 Sep;18(2):174-7.
8
Physicochemical aspects of urolithiasis.尿石症的物理化学方面
Kidney Int. 1978 May;13(5):344-60. doi: 10.1038/ki.1978.53.
Zotero 插件